Correction to: Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Crossref DOI link: https://doi.org/10.1007/s40267-024-01066-9
Published Online: 2024-04-28
Published Print: 2024-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blair, Hannah A.
Text and Data Mining valid from 2024-04-01
Version of Record valid from 2024-04-28
Article History
First Online: 28 April 2024